Q2 net bookings were €5.5 billion of which €2.3 billion was for EUV.

ASML expects Q3 2025 total net sales between €7.4 billion and €7.9 billion, and a gross margin between 50% and 52%

The company expects a full-year 2025 total net sales increase of around 15% relative to 2024, with a gross margin of around 52%

(Figures in millions of euros unless otherwise indicated) Q1 2025 Q2 2025
Net sales 7,742 7,692
…of which Installed Base Management sales 1 2,001 2,096
New lithography systems sold (units) 73 67
Used lithography systems sold (units) 4 9
Net bookings 2 3,936 5,541
Gross profit 4,180 4,130
Gross margin (%) 54.0 53.7
Net income 2,355 2,290
EPS (basic; in euros) 6.00 5.90
End-quarter cash and cash equivalents and short-term investments 9,104 7,248

(1) Installed Base Management sales equals net service and field option sales.
(2) Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

A complete summary of US GAAP Consolidated Statements of Operations is published on www.asml.com.

“Our second-quarter total net sales came in at €7.7 billion, at the top end of our guidance,” said CEO Christophe Fouquet (pictured), “the gross margin was 53.7%, above guidance, primarily driven by higher upgrade business and one-offs resulting in lower costs.

“We see continued progress in litho intensity, particularly in DRAM, and the introduction of the TWINSCAN NXE:3800E reinforces that momentum,” continuedvFouquet, “meanwhile, EUV adoption is advancing as planned, including High NA. This quarter, we shipped the first TWINSCAN EXE:5200B system.”

“Looking at 2026, we see that our AI customers’ fundamentals remain strong,” added Fouquet, “at the same time, we continue to see increasing uncertainty driven by macro-economic and geopolitical developments. Therefore, while we still prepare for growth in 2026, we cannot confirm it at this stage.”

“We expect third-quarter total net sales between €7.4 billion and €7.9 billion, with a gross margin between 50% and 52%,” concluded Fouquet, “we expect R&D costs of around €1.2 billion and SG&A costs of around €310 million. For the full year 2025, we expect a 15% increase in total net sales and a gross margin of around 52%,”